TY - JOUR
T1 - Cytogenetic abnormalities and clinical stage in testicular nonseminomatous germ cell tumors
AU - de Graaff, Willem E.
AU - van Echten-Arends, Jannie
AU - Oosterhuis, J. Wolter
AU - de Jong, Bauke
AU - te Meerman, Gerard J.
AU - Wiersema-Buist, Janneke
AU - Sleijfer, Dirk Th
AU - Schraffordt Koops, Heimen
N1 - Funding Information:
Supported by The Netherlands Cancer Foundation, grant 88-10, and by a grant from the Jan Kornelis de Cock-Stichting, Groningen, The Netherlands.
PY - 1993/10/1
Y1 - 1993/10/1
N2 - To study the impact of chromosomal abnormalities on the clinical behavior of testicular nonseminomatous germ cell tumors (TNSGCTs), we compared the chromosomal constitution of primary tumors of patients who initially presented and remained without metastases to those with metastatic disease. Furthermore, the chromosomal pattern of primary TNSGCTs was compared to ploidy and the clinicopathologic risk factors histology and small-vessel invasion. The modal chromosome number and the ploidy were in agreement. No correlation was found between the modal chromosome number and histology, presence of vascular invasion, or clinical stage. No correlation was found between structural chromosome abnormalities, like the number of copies of the i(12p) chromosome, and clinical stage. No obvious differences were found in chromosomal constitution of metastatic and non-metastatic tumors. The results of the present study suggest that in TNSGCTs differences in clinical behavior are not associated with gross chromosomal differences.
AB - To study the impact of chromosomal abnormalities on the clinical behavior of testicular nonseminomatous germ cell tumors (TNSGCTs), we compared the chromosomal constitution of primary tumors of patients who initially presented and remained without metastases to those with metastatic disease. Furthermore, the chromosomal pattern of primary TNSGCTs was compared to ploidy and the clinicopathologic risk factors histology and small-vessel invasion. The modal chromosome number and the ploidy were in agreement. No correlation was found between the modal chromosome number and histology, presence of vascular invasion, or clinical stage. No correlation was found between structural chromosome abnormalities, like the number of copies of the i(12p) chromosome, and clinical stage. No obvious differences were found in chromosomal constitution of metastatic and non-metastatic tumors. The results of the present study suggest that in TNSGCTs differences in clinical behavior are not associated with gross chromosomal differences.
UR - http://www.scopus.com/inward/record.url?scp=0027423891&partnerID=8YFLogxK
U2 - 10.1016/0165-4608(93)90124-5
DO - 10.1016/0165-4608(93)90124-5
M3 - Article
C2 - 8221606
AN - SCOPUS:0027423891
SN - 0165-4608
VL - 70
SP - 12
EP - 16
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 1
ER -